1.82BMarket Cap
LossP/E TTM
Key Figures
18.800Open
19.380High
1.91MVolume
LossP/E TTM
16.59P/E Dynamic
--Dividend TTM
2.08%Turnover Ratio
19.080Prev. Close
18.210Low
27.03MTurnover
LossP/E Static
3.04P/B
0.00%Div Yield TTM
-15.40%ROA
18.67052wk High
0.82Volume Ratio
-328.50MNet Profit
92.20MShares
-4.8182EPS TTM
--Beta
-64.55%ROE
3.97052wk Low
6.13%Amplitude
17.63%Gross Margin
1.82BMarket Cap
1.54Reward/Risk
4.46%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Fortrea Holdings Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 61 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 20.65.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fortrea Holdings Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Fortrea Holdings Inc Highlights
StrengthsRisks
Fortrea Holdings Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Fortrea Holdings Inc Info
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Ticker SymbolFTRE
CompanyFortrea Holdings Inc
CEOThakrala (Anshul)
Websitehttps://www.fortrea.com/
Shareholders
FAQs
What is the current price of Fortrea Holdings Inc (FTRE)?
The current price of Fortrea Holdings Inc (FTRE) is 19.17.
What is the symbol of Fortrea Holdings Inc?
The ticker symbol of Fortrea Holdings Inc is FTRE.
What is the 52-week high of Fortrea Holdings Inc?
The 52-week high of Fortrea Holdings Inc is 18.67.
What is the 52-week low of Fortrea Holdings Inc?
The 52-week low of Fortrea Holdings Inc is 3.97.
What is the market capitalization of Fortrea Holdings Inc?
The market capitalization of Fortrea Holdings Inc is 1.77B.
Is Fortrea Holdings Inc (FTRE) currently rated as Buy, Hold, or Sell?
According to analysts, Fortrea Holdings Inc (FTRE) has an overall rating of Buy, with a price target of 20.65.
What is the Earnings Per Share (EPS TTM) of Fortrea Holdings Inc (FTRE)?
The Earnings Per Share (EPS TTM) of Fortrea Holdings Inc (FTRE) is -10.81.